Da Silva Jorge Santos serves as Executive at MoonLake Immunotherapeutics, where they oversee executive responsibilities. Since joining the company, Da Silva Jorge Santos has executed 15 insider transactions totaling $13.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 19, 2025 involved exercising options for 196,316 shares valued at $0.
Da Silva Jorge Santos currently holds 3,074,893 shares of MoonLake Immunotherapeutics (MLTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Da Silva Jorge Santos has been a net seller of MLTX stock. They have purchased $0 and sold $13.4M worth of shares.
Da Silva Jorge Santos's most recent insider trade was on Dec 19, 2025, when they sold 196,316 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 9, 2025 | MLTX | $1.0M | Sale | 70,000 | $14.49 | Discretionary |
| Dec 8, 2025 | MLTX | $2.0M | Sale | 130,000 | $15.08 | Discretionary |
| Feb 29, 2024 | MLTX | $264.9K | Sale | 4,740 | $55.89 | Planned |
| Feb 28, 2024 | MLTX | $3.1M | Sale | 56,065 | $55.00 | Planned |
| Feb 27, 2024 | MLTX | $3.5M | Sale | 62,810 | $55.00 | Planned |
| Feb 21, 2024 | MLTX | $62.2K | Sale | 1,125 | $55.27 | Planned |
| Feb 20, 2024 | MLTX | $1.1M | Sale | 20,000 | $57.44 | Planned |
| Feb 16, 2024 | MLTX | $1.2M | Sale | 20,000 | $60.15 | Planned |
| Feb 15, 2024 | MLTX | $1.2M | Sale | 20,000 | $60.18 | Planned |
| Oct 1, 2023 | MLTX | $0 | Disposition | 140,071 | $N/A | Discretionary |
| Oct 1, 2023 | MLTX | $0 | Conversion | 3,027,483 | $N/A | Discretionary |
| Oct 1, 2023 | MLTX | $0 | Disposition | 3,027,483 | $N/A | Discretionary |
| Oct 1, 2023 | MLTX | $0 | Conversion | 140,071 | $N/A | Discretionary |